Citation Impact
Citing Papers
BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
2013
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol
2011 Standout
Gastric cancer
2016 Standout
Metabotropic glutamate receptor 5: a target for migraine therapy
2016
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
2009
Computed Tomography — An Increasing Source of Radiation Exposure
2007 Standout
Attention‐Deficit‐Hyperactivity Disorder: An Update
2009
Contribution of Serotonin Transporter Gene Polymorphisms to Pediatric Migraine
2006
The role and validity of actigraphy in sleep medicine: An update
2011 Standout
The Economic Costs of Pain in the United States
2012 Standout
Crystal Structure of the Ectodomain Complex of the CGRP Receptor, a Class-B GPCR, Reveals the Site of Drug Antagonism
2010
NeuPSIG guidelines on neuropathic pain assessment
2010 Standout
Neurons of the Dopaminergic/Calcitonin Gene-Related Peptide A11 Cell Group Modulate Neuronal Firing in the Trigeminocervical Complex: An Electrophysiological and Immunohistochemical Study
2009
Headache in Schoolchildren: Agreement Between Different Sources of Information
2003
Prevalences of primary headache symptoms at school-entry: a population-based epidemiological survey of preschool children in Germany
2006
Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
2012
Neural mechanism underlying acupuncture analgesia
2008 Standout
Prevalence of Headache in Swedish Schoolchildren, with a Focus on Tension-Type Headache
2004
Descending control of pain
2002 Standout
Opioid Use Among Adolescent Patients Treated for Headache
2014
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators
2012
Botulinum toxin type A for the treatment of migraine
2006
Serendipitous oxidation product of BIBN4096BS: A potent CGRP receptor antagonist
2014
Novel Mutation Confirms Seizure Locus SCN1A is Also Familial Hemiplegic Migraine Locus FHM3
2007
Familial and Sporadic Hemiplegic Migraine: Diagnosis and Treatment
2012
Salivary hypofunction: An update on aetiology, diagnosis and therapeutics
2014
Newer antiepileptic drugs: Possible uses in the treatment of neuropathic pain and migraine
2003
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood–brain barrier
2014
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
The Prevalence of Migraine and Tension-Type Headaches Among Adolescents in Norway. The Nord-Trøndelag Health Study (Head-Hunt-Youth), A Large Population-Based Epidemiological Study
2004
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Hypersexual Disorder: A Proposed Diagnosis for DSM-V
2009 Standout
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
2015
Locomotor networks are targets of modulation by sensory transient receptor potential vanilloid 1 and transient receptor potential melastatin 8 channels
2009 StandoutNobel
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
2014
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice
2011
The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
2008 Standout
Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus
2010
The epidemiology of chronic pain in children and adolescents revisited: A systematic review
2011 Standout
Biological roles of glycans
2016 Standout
Dental caries
2017 Standout
Botulinum Toxin Type A (BOTOX ® ) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double‐Blind, Placebo‐Controlled Trial
2005
Cost‐Effectiveness of Topiramate in Migraine Prevention: Results From a Pharmacoeconomic Model of Topiramate Treatment
2005
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Progress in brain targeting drug delivery system by nasal route
2017
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Calcitonin gene-related peptide: A molecular link between obesity and migraine?
2010
General Principles of Migraine Management: The Changing Role of Prevention
2005
Natural product-based nanoformulations for cancer therapy: Opportunities and challenges
2019 Standout
Botulinum Toxin Type A for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial
2005
The Utility of Neuroimaging in the Evaluation of Children With Migraine or Chronic Daily Headache Who Have Normal Neurological Examinations
2000
The economic cost of brain disorders in Europe
2011 Standout
Prevalence and factors affecting headache in Turkish schoolchildren
2005
Pediatric Idiopathic Intracranial Hypertension
2007
Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study
2005
Cerebellar distribution of calcitonin gene-related peptide (CGRP) and its receptor components calcitonin receptor-like receptor (CLR) and receptor activity modifying protein 1 (RAMP1) in rat
2010
Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial
2016
Reliability of Physical Examination for Diagnosis of Myofascial Trigger Points
2008 Standout
EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force
2009
Current practice and future directions in the prevention and acute management of migraine
2010
A Comparison of Idiopathic Intracranial Hypertension With and Without Papilledema
2009
Changes of Meningeal Excitability Mediated by Corticotrigeminal Networks: A Link for the Endogenous Modulation of Migraine Pain
2010
Deficit of Brain and Skeletal Muscle Bioenergetics and Low Brain Magnesium in Juvenile Migraine: An in Vivo 31P Magnetic Resonance Spectroscopy Interictal Study
1997
Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review
2004
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Botulinum Toxin Type A Prophylactic Treatment of Episodic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Exploratory Study
2006
Pediatric Idiopathic Intracranial Hypertension
2007
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines
2012 Standout
Long‐Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial
2010
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
2014
A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials
2006
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Chronic Daily Headache
2006
Beyond the dmft
2009 Standout
Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
2012
Pediatric Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)
2010
Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion
2010
Chronic Daily Headache: Correlation Between the 2004 and the 1988 International Headache Society Diagnostic Criteria
2004
Trigger point evaluation in migraine patients: an indication of peripheral sensitization linked to migraine predisposition?
2006
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Intranasal Medications for the Treatment of Migraine and Cluster Headache
2004
The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide
2007 Standout
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
2013 Standout
Improvement in Quality of Life and Activity Limitations in Migraine Patients after Prophylaxis. A Prospective Longitudinal Multicentre Study
2005
A Neurologist’s Guide to Acute Migraine Therapy in the Emergency Room
2012
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
2014
Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse
2011
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
2010
RELIEVING PAIN IN AMERICA: A BLUEPRINT FOR TRANSFORMING PREVENTION, CARE, EDUCATION, AND RESEARCH
2012 Standout
Influences on Children's Oral Health: A Conceptual Model
2007
Magnesium in Man: Implications for Health and Disease
2014 Standout
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial
2008
Sumatriptan: a decade of use and experience in the treatment of migraine
2004
Effect of noninvasive vagus nerve stimulation on acute migraine: An open-label pilot study
2014
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
2010 Standout
Diversity‐Oriented Syntheses by Combining CuAAC and Stereoselective INCIC Reactions with Peptides
2017 StandoutNobel
Protein Based Nanostructures for Drug Delivery
2018
Trials of pharmacological interventions for Tourette syndrome: a systematic review.
2013
Discovery, Optimization, and Biological Evaluation of 5-(2-(Trifluoromethyl)phenyl)indazoles as a Novel Class of Transient Receptor Potential A1 (TRPA1) Antagonists
2014 StandoutNobel
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
2013
Peripheral and central nervous system distribution of the CGRP neutralizing antibody [125I] galcanezumab in male rats
2019
The cost of migraine and its treatment.
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
Prospective Analysis of Factors Related to Migraine Attacks: The PAMINA Study
2007 Standout
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
The Importance of Placebo in Headache Research
2008
NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
2012
A Multicentre, Double-Blind, Randomized, Placebo-Controlled, Parallel Group Study of Multiple Treatments of Botulinum Toxin Type A (BoNTA) for the Prophylaxis of Episodic Migraine Headaches
2007
Pathophysiology of Migraine
2012
Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons
2015
Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children
2013 Standout
Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan – A randomised proof-of-concept trial
2010
Gabapentin in the prophylaxis of chronic daily headache
2003
Rising Prevalence of Migraine in Taiwanese Adolescents Aged 13-15 Years
2005
Calcitonin Gene‐Related Peptide ( CGRP ) and Migraine Current Understanding and State of Development
2013
A Potential Preclinical Migraine Model: CGRP-Sensitized Mice.
2009
Pharmacology of the Na v 1.1 domain IV voltage sensor reveals coupling between inactivation gating processes
2017 StandoutNobel
New Appendix Criteria Open for a Broader Concept of Chronic Migraine
2006 Standout
The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop
2015 Standout
Cannabinoids for Medical Use
2015 Standout
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
2014
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
2011
CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016
2016 Standout
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
2010
Operational Diagnostic Criteria for Chronic Migraine: Expert Opinion
2014
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
2010
Eletriptan in the Early Treatment of Acute Migraine: Influence of Pain Intensity and Time of Dosing
2005
A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
2016
Transient Receptor Potential Ankyrin 1 (TRPA1) Channel as Emerging Target for Novel Analgesics and Anti-Inflammatory Agents
2010
Calcitonin Gene-Related Peptide: Physiology and Pathophysiology
2014
Sleep, Sleepiness, and Behavior Problems in Children With Headache
2006
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
2010
Works of Paul Winner being referenced
Botulinum toxins in the treatment of migraine and tension-type headaches
2003
Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: A Randomized, Double‐Blind, Placebo‐Controlled Study
2002
Comparative Efficacy of Eletriptan 40 mg Versus Sumatriptan 100 mg
2003
Classification of Pediatric Migraine: Proposed Revisions to the IHS Criteria
1995
One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study
2000
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Analyses of the 56‐Week PREEMPT Clinical Program
2011
Use of the ICHD‐II Criteria in the Diagnosis of Pediatric Migraine
2005
Office‐Based Treatment of Acute Migraine With Dihydroergotamine Mesylate
1993
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
2017
The Placebo Responder Rate in Children and Adolescents
2005
Overview of pediatric headache
2004
Pediatric headaches: whatʼs new?
1999
Topiramate for Migraine Prevention in Children: A Randomized, Double‐Blind, Placebo‐Controlled Trial
2005
MAP0004, Orally Inhaled Dihydroergotamine for Acute Treatment of Migraine: Efficacy of Early and Late Treatments
2011
Topiramate for Migraine Prevention in Adolescents: A Pooled Analysis of Efficacy and Safety
2006
Idiopathic Intracranial Hypertension in a Young Child Without Visual Symptoms or Signs
1996
Nasal Delivery of Antimigraine Drugs: Clinical Rationale and Evidence Base
2006
Migraine Preventive Medication Reduces Resource Utilization
2003
Eletriptan for the Acute Treatment of Migraine in Adolescents: Results of a Double‐Blind, Placebo‐Controlled Trial
2007
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
2008
Sumatriptan Nasal Spray in Adolescent Migraineurs: A Randomized, Double‐Blind, Placebo‐Controlled, Acute Study
2006
Early intervention in migraine with sumatriptan tablets50 mg versus 100 mg: A pooled analysis of data from six clinical trials
2005
Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: Results From a Double‐Blind, Single‐Attack Study and Two Open‐Label, Multiple‐Attack Studies
2004
Chronic Daily Headache Prophylaxis With Tizanidine: A Double‐Blind, Placebo‐Controlled, Multicenter Outcome Study
2002
Chronic Daily Headache in Children and Adolescents:Current Status and Recommendations for the Future
1997
Zolmitriptan Oral Tablet in Migraine Treatment: High Placebo Responses in Adolescents
2006
Pain-Free Results With Sumatriptan Taken at the First Sign of Migraine Pain: 2 Randomized, Double-Blind, Placebo-Controlled Studies
2003
Multicenter Prospective Evaluation of Proposed Pediatric Migraine Revisions to the HIS Criteria
1997
Efficacy of Zolmitriptan Nasal Spray in Adolescent Migraine
2007
Prevalence and Burden of Chronic Migraine in Adolescents: Results of the Chronic Daily Headache in Adolescents Study (C‐dAS)
2011
Total Migraine Freedom, a Potential Primary Endpoint to Assess Acute Treatment in Migraine: Comparison to the Current FDA Requirement Using the Complete Rizatriptan Study Database
2010
Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders
2005
An Open‐Label Dose‐Titration Study of the Efficacy and Tolerability of Tizanidine Hydrochloride Tablets in the Prophylaxis of Chronic Daily Headache
2001
A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents
2000
Atomoxetine Treatment of ADHD in Children With Comorbid Tourette Syndrome
2007